Teligent Inc (TLGT) Expected to Announce Earnings of -$0.02 Per Share

Analysts predict that Teligent Inc (NASDAQ:TLGT) will report earnings of ($0.02) per share for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Teligent’s earnings, with the highest EPS estimate coming in at $0.01 and the lowest estimate coming in at ($0.04). Teligent reported earnings of ($0.06) per share in the same quarter last year, which indicates a positive year-over-year growth rate of 66.7%. The firm is expected to announce its next earnings report before the market opens on Monday, March 18th.

According to Zacks, analysts expect that Teligent will report full-year earnings of ($0.12) per share for the current financial year, with EPS estimates ranging from ($0.14) to ($0.09). For the next financial year, analysts forecast that the company will report earnings of $0.04 per share, with EPS estimates ranging from ($0.07) to $0.15. Zacks Investment Research’s EPS calculations are an average based on a survey of sell-side research firms that cover Teligent.

Get Teligent alerts:

Several research firms have weighed in on TLGT. ValuEngine raised Teligent from a “sell” rating to a “hold” rating in a research note on Wednesday, January 2nd. Canaccord Genuity lowered their target price on Teligent from $4.00 to $3.00 and set a “hold” rating on the stock in a research note on Friday, November 16th.

NASDAQ:TLGT opened at $1.46 on Tuesday. The company has a debt-to-equity ratio of 3.30, a quick ratio of 0.86 and a current ratio of 1.31. Teligent has a fifty-two week low of $1.13 and a fifty-two week high of $4.52. The stock has a market cap of $76.89 million, a price-to-earnings ratio of -7.68 and a beta of 1.59.

A number of large investors have recently added to or reduced their stakes in TLGT. Prosight Management LP grew its stake in Teligent by 9.5% during the 4th quarter. Prosight Management LP now owns 3,547,607 shares of the company’s stock valued at $4,860,000 after acquiring an additional 306,846 shares in the last quarter. Elk Creek Partners LLC grew its stake in shares of Teligent by 6.0% in the 4th quarter. Elk Creek Partners LLC now owns 4,880,589 shares of the company’s stock valued at $6,686,000 after buying an additional 277,834 shares in the last quarter. SCW Capital Management LP bought a new stake in shares of Teligent in the 4th quarter valued at approximately $363,000. Bridgeway Capital Management Inc. grew its stake in shares of Teligent by 112.7% in the 3rd quarter. Bridgeway Capital Management Inc. now owns 283,081 shares of the company’s stock valued at $1,118,000 after buying an additional 150,000 shares in the last quarter. Finally, GSA Capital Partners LLP bought a new stake in shares of Teligent in the 4th quarter valued at approximately $192,000. 64.73% of the stock is currently owned by institutional investors.

About Teligent

Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, and markets generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. The company sells generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms.

Featured Article: What is a Lock-Up Period?

Get a free copy of the Zacks research report on Teligent (TLGT)

For more information about research offerings from Zacks Investment Research, visit Zacks.com